These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Risks and benefits of phase 1 oncology trials, revisited. Kurzrock R; Benjamin RS N Engl J Med; 2005 Mar; 352(9):930-2. PubMed ID: 15745986 [No Abstract] [Full Text] [Related]
9. Adaptive design may hasten clinical trials. Schmidt C J Natl Cancer Inst; 2007 Jan; 99(2):108-9. PubMed ID: 17227993 [No Abstract] [Full Text] [Related]
10. Phase II clinical trials in oncology: are we hitting the target? Ang MK; Tan SB; Lim WT Expert Rev Anticancer Ther; 2010 Mar; 10(3):427-38. PubMed ID: 20214523 [TBL] [Abstract][Full Text] [Related]
11. [The investigational strategy and present status of hepatic arterial infusion chemotherapy for liver metastasis for colorectal cancer]. Arai Y Gan To Kagaku Ryoho; 1993 Dec; 20(16):2467-71. PubMed ID: 8279843 [TBL] [Abstract][Full Text] [Related]
12. Developing drugs that do not cause tumor regression. Stadler W Clin Adv Hematol Oncol; 2003 Nov; 1(11):654-5. PubMed ID: 16258462 [No Abstract] [Full Text] [Related]